Sort
50,496 grants matching “lung cancer”
Molecular Dynamics Simulations Of Biological Macromolecules
$611,398Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities
$611,389Bruce L. Jacobs · University Of Pittsburgh At Pittsburgh · R37 · FY2023 · CA
Determinants of acquired resistance in small cell lung cancer
$611,353Charles M Rudin · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Targeting plasticity in lung cancer
$611,289Tuomas Tammela · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Immunology Team Contributions to the LSB
$611,223Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
$610,974Andrei Goga · University Of California, San Francisco · R01 · FY2012 · CA
Spectral Markers for Early Detection of Colon Neoplasia
$610,966Hemant K Roy · Endeavor Health Clinical Operations · U01 · FY2011 · CA
Infections, immunity, and inflammation in cancer
$610,884Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Role of DeltaNp63 alpha and TIP60 in SCC progression and chemoresistance
$610,770Madhavi P Kadakia · Wright State University · R01 · FY2025 · CA
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
$610,696Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2013 · CA
Precision prevention strategy to increase uptake and engagement in lung cancer screening and smoking cessation treatment
$610,668Alex Taylor Ramsey · Washington University · R01 · FY2024 · CA
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry
$610,662Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
DECIPHERING EPIGENETIC MECHANISMS THAT DICTATE POOR RESPONSES TO KRAS INHIBITION IN LUNG CANCER
$610,656The Trustees Of Columbia University In The City Of New York · · FY2025 · Defense Health Agency
Functional Determinants of Metastatic Dormancy
$610,641Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · R01 · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$610,603Brad Kahl · University Of Wisconsin-Madison · U10 · FY2008 · CA
Preoperative Respiratory Muscle Training to Prevent Postoperative Pulmonary Complications in Patients Undergoing Resection for Lung Cancer
$610,513Andrew Donald Ray · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Imaging of Stromal Cells in the Tumor Microenvironment
$610,511Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2009 · CA
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$610,502Gregory M Lanza · Washington University · R01 · FY2022 · CA
Target discovery and combination therapy in KRAS mutant cancer
$610,483Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Organoid models of KRAS mutant cancer
$610,483Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Fox COBRE Phase II Admin Core
$610,481Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
CCR Confocal Microscopy Core
$610,439Susan Garfield · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Role of METTL3 and the m6A Epitranscriptome in cancer
$610,370Richard I. Gregory · Boston Children'S Hospital · R01 · FY2024 · CA
The use of chitosan for cancer vaccine delivery
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The connection of innate and adaptive anti-cancer immunity
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA